The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Day Wesley since 2006.
The trader's CIK number is 1341526.
At the time of the last reporting, Day Wesley was the VP, Clinical Researc of Vivus Inc. (stock ticker symbol VVUS).
Also see all insider trading activities at Vivus Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | VVUS | 0 | $0 | 8,353 | $19,595 | 0 | $0 |
| 2012 | VVUS | 0 | $0 | 126,758 | $2,509,379 | 109,958 | $412,395 |
| 2011 | VVUS | 0 | $0 | 23,442 | $231,349 | 23,442 | $75,131 |
| 2010 | VVUS | 0 | $0 | 66,600 | $635,497 | 60,000 | $195,600 |
| 2008 | VVUS | 3,297 | $13,758 | 0 | $0 | 0 | $0 |
| 2007 | VVUS | 7,348 | $26,125 | 0 | $0 | 0 | $0 |
| 2006 | VVUS | 6,198 | $20,176 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-07-01 | VVUS | Sale | 7,881 | 2.32 | 18,283 |
| 2015-01-29 | VVUS | Sale | 472 | 2.78 | 1,312 |
| 2012-07-18 | VVUS | Sale | 16,800 | 30.36 | 510,048 |
| 2012-02-23 | VVUS | Option Ex | 79,958 | 3.93 | 313,995 |
| 2012-02-23 | VVUS | Sale | 79,958 | 20.69 | 1,654,331 |
| 2012-01-09 | VVUS | Sale | 30,000 | 11.50 | 345,000 |
| 2012-01-09 | VVUS | Option Ex | 30,000 | 3.28 | 98,400 |
| 2011-11-11 | VVUS | Option Ex | 23,442 | 3.21 | 75,131 |
| 2011-11-11 | VVUS | Sale | 23,442 | 9.87 | 231,349 |
| 2010-12-17 | VVUS | Sale | 66,600 | 9.54 | 635,497 |
| 2010-12-17 | VVUS | Option Ex | 60,000 | 3.26 | 195,600 |
| 2008-05-14 | VVUS | Buy | 3,297 | 4.17 | 13,758 |
| 2007-11-14 | VVUS | Buy | 3,104 | 4.23 | 13,139 |
| 2007-05-14 | VVUS | Buy | 4,244 | 3.06 | 12,986 |
| 2006-11-14 | VVUS | Buy | 2,198 | 2.99 | 6,576 |
| 2006-03-02 | VVUS | Buy | 4,000 | 3.40 | 13,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Day Wesley (VP, Clinical Researc of Vivus Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.